There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07K16/2818
Pages in category "CPC C07K16/2818"
The following 86 pages are in this category, out of 86 total.
1
- 18018660. COMPOSITIONS INCLUDING SOLID FORMS OF POLYPEPTIDES AND RELATED METHODS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)
- 18438746. METHODS OF TREATING CANCER PAIN BY ADMINISTERING A PD-1 INHIBITOR simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)
- 18680465. ANTIBODY MOLECULES TO PD-1 AND USES THEREOF (President and Fellows of Harvard College)
2
- 20250154256. An (Augusta University Research Institute, Inc.)
- 20250154257. Treatment Of Lung (Bristol-Myers Squibb Company)
- 20250154258. Methods Of Treati (Bristol-Myers Squibb Company)
- 20250163155. Combination (Bristol-Myers Squibb)
- 20250163156. Novel Mono (Wuxi Biologics (Shanghai) ., .)
- 20250171541. Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte Associated Protein 4 (ctla-4 (THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA)
- 20250179182. Methods Treating Cancer (SEAGEN .)
- 20250179183. Nk/monocyte Engagers (Biomolecular Holdings LLC)
- 20250179184. Foxp1-ablated Ch (H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, .)
- 20250188164. Pharmaceutical Com (AKESO PHARMACEUTICALS, .)
- 20250188165. Combinations (Trishula Therapeutics)
- 20250215086. Anti-pd-1 Antibody Formulations (AMGEN .)
- 20250215087. Combination Thera (Bristol-Myers Squibb)
- 20250215088. Combination Therapy F (TERSESA THERAPEUTICS LLC)
- 20250230242. Pharmaceutical Composition Anti-tim-3 Antib (NANJING SHUNXIN PHARMACEUTICALS ., . OF CHIATAI TIANQING PHARM. GROUP)
- 20250230243. Prediction Chemot (Foundation Medicine, .)
A
- AbbVie Inc. Patent Application Trends in 2025
- Ablynx N.V Patent Application Trends in 2024
- Ablynx N.V. Patent Application Trends in 2024
- Akeso Pharmaceuticals, Inc. Patent Application Trends in 2024
- Amgen Inc. Patent Application Trends in 2024
- AMGEN INC. Patent Application Trends in 2025
- AstraZeneca AB Patent Application Trends in 2024
B
C
D
G
H
I
J
N
R
S
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- The Board of Regents of the University of Texas System Patent Application Trends in 2024
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2025
- The Johns Hopkins University Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Patent Application Trends in 2024
- The Trustees of Columbia University in the City of New York Patent Application Trends in 2024
- The University of Hong Kong Patent Application Trends in 2024
- Trustees of Dartmouth College Patent Application Trends in 2024
- TRUSTEES OF DARTMOUTH COLLEGE Patent Application Trends in 2025
- Trustees of Dartmouth College Patent Application Trends in 2025